Newark, DE, United States of America

Richard Scott Alexander

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 10.6

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations by Richard Scott Alexander

Introduction

Richard Scott Alexander is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of medical treatments, particularly through his innovative work on matrix metalloproteinases. With a total of 9 patents to his name, Alexander's inventions are paving the way for advancements in therapeutic methods.

Latest Patents

Among his latest patents, Alexander has developed methods of treatment using allosteric processing inhibitors for matrix metalloproteinases. This invention includes a crystal comprising a complex of the pro form of a matrix metalloprotease (proMMP) and a small-molecule allosteric processing inhibitor that inhibits the activation of the proMMP. The invention also relates to the crystal structure of a complex of proMMP9 bound to a small-molecule allosteric processing inhibitor that inhibits activation of proMMP9. Furthermore, it encompasses methods for identifying small-molecule allosteric processing inhibitors and their application in treating diseases mediated by inappropriate matrix metalloproteinase activity.

Career Highlights

Richard Scott Alexander is currently associated with Janssen Pharmaceutica NV, where he continues to innovate and contribute to the field of pharmaceuticals. His work is instrumental in developing new treatment methodologies that can significantly impact patient care.

Collaborations

Some of his notable coworkers include Kristi A Leonard and Frank A Lewandowski. Their collaborative efforts enhance the research and development processes within their organization.

Conclusion

Richard Scott Alexander's contributions to the field of medical treatments through his patents demonstrate his commitment to innovation and improving healthcare solutions. His work continues to inspire advancements in the treatment of diseases related to matrix metalloproteinases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…